Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-048093
Filing Date
2024-05-31
Accepted
2024-05-30 19:38:12
Documents
93
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0206003-10q_avalon.htm   iXBRL 10-Q 1172122
2 SECURITY PURCHASE AGREEMENT, DATED MARCH 7, 2024, BETWEEN AVALON GLOBOCARE CORP. ea020600301ex10-3_avalon.htm EX-10.3 177776
3 SENIOR SECURED CONVERTIBLE PROMISSORY NOTE, DATED MARCH 7, 2024, BETWEEN AVALON ea020600301ex10-4_avalon.htm EX-10.4 123998
4 SECURITY AGREEMENT, DATED MARCH 7, 2024, BETWEEN AVALON GLOBOCARE CORP. AND MAST ea020600301ex10-5_avalon.htm EX-10.5 158147
5 WARRANT, DATED MARCH 7, 2024, BETWEEN AVALON GLOBOCARE CORP. AND MAST HILL FUND, ea020600301ex10-6_avalon.htm EX-10.6 274922
6 CERTIFICATION ea020600301ex31-1_avalon.htm EX-31.1 11418
7 CERTIFICATION ea020600301ex31-2_avalon.htm EX-31.2 11731
8 CERTIFICATION ea020600301ex32-1_avalon.htm EX-32.1 4398
9 CERTIFICATION ea020600301ex32-2_avalon.htm EX-32.2 4310
  Complete submission text file 0001213900-24-048093.txt   8642783

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE avco-20240331.xsd EX-101.SCH 87475
11 XBRL CALCULATION FILE avco-20240331_cal.xml EX-101.CAL 46654
12 XBRL DEFINITION FILE avco-20240331_def.xml EX-101.DEF 422997
13 XBRL LABEL FILE avco-20240331_lab.xml EX-101.LAB 717935
14 XBRL PRESENTATION FILE avco-20240331_pre.xml EX-101.PRE 421867
97 EXTRACTED XBRL INSTANCE DOCUMENT ea0206003-10q_avalon_htm.xml XML 824320
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 732-780-4400
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

EIN.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38728 | Film No.: 241007181
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)